Who Owns AgomAb Therapeutics NV Stock?
NASDAQ: AGMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 53.72%
- Held by insiders
- 5.94%
- Institutional holders
- 37
- Institutions 53.7%
- Insiders 5.9%
- Public and other 40.3%
Who owns AgomAb Therapeutics NV stock?
Institutional investors own about 53.7% of AgomAb Therapeutics NV's shares, spread across 37 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 5.94% of AGMB.
The largest institutional holders are Eqt Fund Management S.a R.l. (10.44%), Sanofi (5.65%) and Redmile Group, LLC (5.55%). Together, the top 10 institutions control 46.5% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their AGMB positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AGMB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Eqt Fund Management S.a R.l. | 5.14M | 10.44% | 0.0% |
| Sanofi | 2.78M | 5.65% | 0.0% |
| Redmile Group, LLC | 2.73M | 5.55% | +1649.7% |
| Cormorant Asset Management, LP | 2.47M | 5.01% | 0.0% |
| TCG Crossover Management, LLC | 2.05M | 4.17% | 0.0% |
| Federated Hermes, Inc. | 1.62M | 3.29% | 0.0% |
| Nantahala Capital Management, LLC | 1.57M | 3.18% | +30.7% |
| Casdin Capital, LLC | 1.55M | 3.15% | 0.0% |
| Andera Partners | 1.54M | 3.12% | 0.0% |
| FMR, LLC | 1.46M | 2.96% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AGMB
| Fund | Shares | % Held |
|---|---|---|
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 981.18K | 1.99% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 615.71K | 1.25% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 507.25K | 1.03% |
| abrdn Healthcare Investors | 363.50K | 0.74% |
| abrdn World Healthcare Fund | 312.73K | 0.64% |
| abrdn Life Sciences Investors | 170.46K | 0.35% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 141.98K | 0.29% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 129.20K | 0.26% |
| Federated Hermes Insurance Series-Federated Hermes Kaufmann Fund II | 21.11K | 0.04% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 17.66K | 0.04% |
Frequently asked questions
Who is the largest shareholder of AgomAb Therapeutics NV?
Eqt Fund Management S.a R.l. is the largest institutional shareholder of AGMB, owning 10.44% of shares outstanding (5.14M shares) as of its latest 13F filing.
What percentage of AgomAb Therapeutics NV is owned by institutions?
Institutions own about 53.7% of AGMB shares and 57.1% of the public float.
How much of AgomAb Therapeutics NV do insiders own?
Insiders, such as officers and directors, own about 5.94% of AGMB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.